Yaksa Scientific Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 19-12-2024
- Paid Up Capital ₹ 0.10 M
as on 19-12-2024
- Company Age 3 Year, 6 Months
About Yaksa Scientific Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jimmy Solanki and Rachana Parmar serve as directors at the Company.
- CIN/LLPIN
U85100GJ2021PTC123958
- Company No.
123958
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jul 2021
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Yaksa Scientific Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jimmy Solanki  | Director | 08-Jul-2021 | Current |
| Rachana Parmar | Director | 08-Jul-2021 | Current |
Financial Performance of Yaksa Scientific Laboratories.
Enhance accessibility to Yaksa Scientific Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Yaksa Scientific Laboratories?
Unlock access to Yaksa Scientific Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Markat Pharmaceuticals Private LimitedActive 4 years 2 monthsJimmy Solanki and Rachana Parmar are mutual person
Yaksa Pharmaceuticals Private LimitedActive 3 years 6 monthsJimmy Solanki and Rachana Parmar are mutual person
- Markat Global Private LimitedActive 10 months 17 days
Jimmy Solanki and Rachana Parmar are mutual person
- Yaksa Entertainment Private LimitedActive 3 years 6 months
Jimmy Solanki and Rachana Parmar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Yaksa Scientific Laboratories?
Yaksa Scientific Laboratories has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yaksa Scientific Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yaksa Scientific Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
